AML 3.0 by IDMERIT is redefining what modern anti money laundering software looks like - faster screening, smarter monitoring ...
The study focuses on patients unlikely to benefit from azacitidine/venetoclax or showing early resistance. ・SLS009 showed ...
Stocktwits on MSN
SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail
The debate centers on Sellas’ Phase 3 Regal trial, which is testing its immunotherapy Galinpepimut-S (GPS) as a maintenance ...
London, UK, March 4th, 2026, FinanceWireAML Union today announced the implementation of enhanced internal compliance ...
The rule is already prompting operational changes, new workflows and questions from buyers and sellers first encountering the requirements.
AML Incubator (AMLI) is a Canadian compliance advisory firm supporting fintechs, MSBs, payment providers, and payments and financial platforms with AML program design, remediation, and regulatory ...
New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.
The therapeutic arsenal for the management of AML has expanded significantly in recent years. Before 2017, newly diagnosed AML was treated with either standard cytarabine- and anthracycline-based ...
Diligent AI is developing autonomous AI analysts to automate financial crime compliance, aiming to reduce manual workload and ...
In a joint submission to the Department of Home Affairs’ consultation on the draft Anti-Money Laundering and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results